Abstract: The invention relates to the use of compounds which exhibit an affinity for the ?-opioid receptor of at least 100 nM (Ki value, human) and an affinity for the ORL-1 receptor, wherein the ratio between the affinities ORL1/? defined as 1/[Ki(ORL1)/Ki(?)] is from 0.1 to 30, for the treatment of pain.
Type:
Application
Filed:
September 28, 2007
Publication date:
May 29, 2008
Applicant:
GRUNENTHAL GMBH
Inventors:
KLAUS LINZ, Babette-Yvonne Kogel, Wolfgang Schroder, Thomas Christoph, Jean De Vry, Elmar Friderichs